Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
Webcast
0.5 AMA PRA Category 1 Credit™ ...OVERVIEW
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey is organized by Omnia Education.
Release Date: 08/09/2024
Expiration Date: 08/09/2025
Description:
GnRH antagonists have emerged as a viable first-line (or subsequent-line) medical therapy for the management of endometriosis. They have proven to be effective and safe, and their use avoids the flare response observed with GnRH agonists. Join Drs. Lee Shulman, Ayman Al-Hendy, and Sawsan As-Sanie as they discuss the estrogen threshold hypothesis from the perspective of GnRH antagonists and delve into clinical data supporting the use of GnRH antagonists in the medical management of endometriosis.
Learning Objectives
After participating in this educational activity, participants should be better able to:
- Identify the benefits and disadvantages of the GnRH antagonists in the management of endometriosis
ACCREDITATION & CREDITS
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for .5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for .5 AAPA Category 1 CME credits. Approval is valid until August 9, 2025. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for .5 contact hours/0.05 CEUs of pharmacy contact hours.
The Universal Activity Number for this program is JA0006235-0000-24-077-H01-P. This learning activity is knowledge-based. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity.
TARGET AUDIENCE
PhysicianNursingPharmacistPhysician AssistantPrimary Care PhysicianNursesHealthcare ProvidersNurse PractitionersGynaecologistSPECIALITIES
Obstetrics and GynecologyRELATED ONLINE COURSES
By ImageSim Corporation
Webcast
Pediatrics
33 AMA PRA Category 1 Credits™
...
...
Quick Links